In Argentina, with the assistance of the Russian Fund of Direct Investments (RDI), conducted studies of combinations of the Russian vaccine “Satellite V” with preparations of foreign production. The results of the test reported Deputy Minister of Health Coenos Aires Daniel Ferrande, reports TASS.
According to Ferrante, the combination of the first component of the Russian vaccine from the coronavirus “satellite V” with the American company Moderna showed a good result. “When combinations of” satellite V “with Moderna, a stronger immune response is observed,” he said.
The official also revealed the results of vaccination comparisons with two components of the “satellite V” and combinations of a Russian drug with Astrazeneca. Ferrande said that during the study there was no significant change in immunogenicity. The results of combinations of the “satellite V” and the Chinese drug SINOPHARM are still analyzed.
Deputy Minister noted that during the tests there were no differences in the development of side effects. “There was no hospitalization,” he concluded.
Earlier in the RFI, they stated that the combination of the Russian Satellite Light vaccine with Astrazeneca vaccines, Sinopharm and Moderna demonstrated high safety rates during the study in Argentina. The domestic drug was used in combination with other vaccines both as the first and second (busty) injection.